Drug-Drug Interaction Study Between Colchicine and Cyclosporine

Completed · Phase 1

Conditions studied: Pharmacokinetics, Healthy

In brief

Colchicine is a substrate for both cytochrome P450 3A4 (CYP3A4) and P-glycoprotein (P-gp). Cyclosporine is a potent inhibitor of both CYP3A4 and P-gp. This study will evaluate the effect of single-dose cyclosporine on the pharmacokinetic profile of a single 0.6 mg dose of colchicine. A secondary objective is to evaluate the safety and tolerability of this regimen in healthy volunteers. All study subjects will be monitored for adverse events throughout the study period

Key facts

Study ID
NCT00983931
Run by
Mutual Pharmaceutical Company, Inc.
People needed
24
Starts
2008-08-01
Expected to finish
2008-09-01
Last updated by the study team
2009-10-15

Who can join

Age: 18 and older, up to 45. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.